17th May 2016 08:03
LONDON (Alliance News) - Cancer drug discovery firm Sareum Holdings PLC on Tuesday said it has appointed Stephen Parker as its new non-executive chairman.
Parker takes over from Paul Harper with immediate effect, Sareum said.
Parker is currently the chairman of Silence Therapeutics PLC, the AIM-listed firm focused on developing ribonucleic acid therapeutics for serious diseases.
Shares in Sareum were up 3.0% to 0.881 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
SLN.LSareum